Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126704301 | 12670430 | 1 | I | 20160704 | 20160801 | 20160822 | 20160822 | EXP | GB-GLAXOSMITHKLINE-GB2016111159 | GLAXOSMITHKLINE | 74.00 | YR | M | Y | 0.00000 | 20160822 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126704301 | 12670430 | 1 | PS | KIVEXA | ABACAVIR SULFATELAMIVUDINE | 1 | Unknown | STRENGTH:600MG/300MG | U | 21652 | TABLET | ||||||||
| 126704301 | 12670430 | 2 | SS | VIRAMUNE | NEVIRAPINE | 1 | Unknown | STRENGTH:400 MG, PROLONGED-RELEASE | U | 0 | PROLONGED-RELEASE TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126704301 | 12670430 | 1 | Product used for unknown indication |
| 126704301 | 12670430 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126704301 | 12670430 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126704301 | 12670430 | Cardiac disorder | |
| 126704301 | 12670430 | Myocardial infarction | |
| 126704301 | 12670430 | Renal disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |